Active TB drug-safety monitoring and management (aDSM)

Overview

Adverse drug reactions can lead to a tuberculosis (TB) patient interrupting treatment before completion, and can thus contribute to avoidable morbidity, drug-resistance, treatment failure, reduced quality of life, or even death. 

WHO Team
Global Programme on Tuberculosis and Lung Health (GTB)
Number of pages
2